The United Soccer League (USL) announced an expanded, multi-year partnership with Kitman Labs to roll out its Performance Medicine Solution across every USL Championship club. The deal represents a substantial investment in league-wide medical infrastructure, signaling a decisive move to standardize health and performance data management throughout the competition.
Central to the agreement is the adoption of Kitman Labs' iP:Intelligence Platform, an enterprise-grade operating system that aggregates medical records, physical performance metrics, and contextual information into a single, actionable dashboard. By doing so, the platform enables clubs to make smarter, data-driven decisions that protect player health and optimize on-field output.
Paul McDonough, President and CEO of the USL, highlighted the strategic importance of this investment, stating that elevating professional standards and safeguarding athlete welfare are non‑negotiable priorities for the league. His remarks underscore a broader ambition to embed cutting‑edge medical technology into the fabric of American soccer.
Stephen Smith, Founder and CEO of Kitman Labs, expressed pride in extending the partnership with the USL, noting that the collaboration builds on the proven success of the iP:Intelligence Platform in the Gainbridge Super League. Smith emphasized the shared commitment to creating scalable, consistent health standards for athletes at the highest level.
The partnership also paves the way for the upcoming launch of USL Premier, the league's new Division One men's professional circuit. Clubs slated for Premier will inherit the same Performance Medicine platform, ensuring a seamless transition and uniform health protocols across the entire USL ecosystem.
Beyond immediate operational benefits, the alliance reflects a long‑term vision of player development and injury prevention. By centralizing data collection and analysis, the USL aims to reduce downtime, accelerate recovery, and ultimately deliver a higher‑quality product for fans and stakeholders alike.
A New Standard for Athlete Medical Intelligence
The expanded collaboration marks a pivotal moment for sports science in North America, setting a benchmark that other leagues may seek to emulate. As the iP:Intelligence Platform becomes the backbone of medical decision‑making across the USL, the ripple effects could reshape how professional soccer approaches health, performance, and fan confidence.
With the infrastructure now in place, the league is poised to monitor player wellness in real time, adjust training loads dynamically, and intervene early when risk factors emerge. This proactive stance not only protects athletes but also enhances the competitive integrity of the sport.